drugset / Trial / NCT02476019
A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ISIS-FGFR4RX.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-07
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISIS-463588 | Antisense oligonucleotide | — | Subcutaneous |